In the world of insurance finance, two regulatory giants dictate how we measure our obligations: IFRS 17 for financial reporting and Solvency II for prudential regulation. While both aim for a realistic view of the balance sheet, they answer different questions. IFRS 17 asks, 'How is this contract performing over time?' while Solvency II asks, 'Do we have enough capital to meet our obligations right now?' This distinction is critical when we look at their core component: the valuation of technical provisions.
The Common Ground: Best Estimate Cash Flows
Let’s start with the good news. Both IFRS 17 and Solvency II are built on a common foundation: a best estimate of future cash flows. This involves projecting all expected future premiums, claims, and expenses related to insurance contracts and then discounting them to a present value. This shared starting point, often called the Best Estimate Liability (BEL) in Solvency II terms, allows for significant synergies in data, assumptions, and modeling. But this is where the similarities end and the crucial differences begin.
The Great Divide: Accounting for Profit and Risk
Beyond the best estimate cash flows, the two frameworks diverge significantly in how they account for future profits and the uncertainty around those cash flows. It’s here that we meet the key building blocks that define each standard.
Under IFRS 17, the total liability is comprised of:
* Liability for Remaining Coverage (LRC): The best estimate cash flows for future service, plus a Risk Adjustment (RA) for non-financial risk, and the pivotal Contractual Service Margin (CSM), which represents unearned profit.
* Liability for Incurred Claims (LIC): The best estimate cash flows for past events, plus a Risk Adjustment.
Under Solvency II, the technical provisions are simply:
* The Best Estimate Liability (BEL).
* The Risk Margin (RM).
The core divergence lies in the CSM versus the lack thereof, and the Risk Adjustment versus the Risk Margin.
The CSM: A Lockbox for Future Profits
The Contractual Service Margin (CSM) is perhaps the most significant innovation of IFRS 17. It is the unearned profit on a group of contracts that is established at inception. This profit is then released systematically into the income statement over the life of the contracts as services are provided. Its purpose is to prevent the recognition of 'day one' profits, leading to a smoother earnings pattern. Solvency II has no such concept. Any expected profit in a contract directly increases an insurer's 'Own Funds'—its available capital—from the moment the contract is signed.
Risk Adjustment vs. Risk Margin: A Question of Perspective
Both frameworks add a buffer to the best estimate to account for uncertainty, but their philosophies are worlds apart.
The IFRS 17 Risk Adjustment (RA) is an entity-specific measure. It represents the compensation the company requires for bearing the non-financial risks of the contract (like claims being higher or later than expected). The methodology and confidence level are determined by the insurer, reflecting its own risk appetite.
The Solvency II Risk Margin (RM), however, is not about the insurer's own view. It is a market-consistent, hypothetical value. It represents the theoretical cost another undertaking would charge to take over the liabilities, calculated prescriptively as the cost of holding the required regulatory capital (SCR) for the lifetime of the obligations. It is an 'exit value' from a market perspective.
What This Means for Your Business
These differences are not just for actuaries to debate. They have tangible business implications. You must maintain two separate but related valuation frameworks, impacting systems, processes, and reporting timelines. The different profit signatures—smooth and deferred under IFRS 17 versus immediate under Solvency II—affect everything from investor relations and executive compensation to product pricing and strategic planning. Understanding both narratives is no longer optional; it's essential for sound financial management and clear communication with all stakeholders.
Need Help With Your IFRS 17 Valuation?
Our qualified actuaries can help you with discount rate selection, assumption setting, and full IFRS 17 valuations.
Get a Quote